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ABBREVIATION
CSF Cerebrospinal fluid
AIM To describe trends in walking and living independently in a cohort of consecutive cases
of spina bifida, followed-up over 50 years.
METHOD From 1972 to 2017, a cohort of 117 (born 1963–1971, 50 males, 67 females)
survivors and/or carers was surveyed approximately every 5 years by clinical examination
and/or postal questionnaire/telephone interview. The Office for National Statistics provided
details of deaths.
RESULTS The follow-up in 2016 and 2017 was 99% (116/117). There were 37 survivors (17
males, 20 females) aged 46 to 53 years and 79 deaths (50y survival, 32%). The percentage of
survivors who could walk more than 50m at the mean ages of 9 years, 18 years, 25 years, 30
years, 35 years, 40 years, 45 years, and 50 years was 51% (38/75), 50% (34/68), 33% (20/61),
30% (17/57), 30% (16/54), 30% (14/46), 31% (12/39), and 27% (10/37) respectively. However, the
percentage living independently in the community after age 25 years increased over time:
23% (14/61); 37% (21/57); 41% (22/54); 39% (18/46); 56% (22/39); and 54% (20/37). Living
independently at age 50 years was more common in survivors without a history of raised
intracranial pressure or cerebrospinal fluid shunt revisions.
INTERPRETATION In this unselected cohort, mobility declined with age, possibly because of
increasing obesity and deteriorating health. By contrast, partly because survival was better in
those least disabled, the percentage living independently increased.
Myelomeningocele (a type of spina bifida) is the most com-
mon congenital abnormality causing physical disability.1
Almost 6000 affected infants were born in Europe between
1991 and 2011. Worldwide incidence is 0.2 to 6.4 per
1000 live births with higher rates in less developed coun-
tries.2,3 Severity varies from no apparent disability to major
health problems including paralysis, cognitive impairment,
and bladder and bowel dysfunction.4,5 Average lifetime cost
of care is estimated at over €500 000.
Recently, there have been calls for reliable longitudinal
data on trends in walking and living independently in
patients with spina bifida.1,4,6 Doctors, parents, and health
care planners want to know if children with a disability,
such as spina bifida, will be able to look after themselves in
adulthood.7 For example, will they achieve emerging adult-
hood milestones such as leaving home or gaining employ-
ment?8 Cross-sectional studies fail to answer such crucial
questions adequately, while most longitudinal studies have
been of relatively short duration and/or had high loss to
follow-up.4,9,10 This is the rationale for the current study
in which we followed up a cohort of patients with spina
bifida from Cambridge, UK for 50 years. We describe
trends in walking at the mean ages of 9 years, 18 years, 25
years, 30 years, 35 years, 40 years, 45 years, and 50 years.
Since many young people live at home in early adulthood,
we investigated trends in living independently from age
25 years onwards. We also explored possible predictors of
walking or living independently at mean age 50 years.9–14
METHOD
Participants
As previously described,11,15–17 the cohort comprised 117
consecutive infants (50 males, 67 females) with open
myelomeningocele/spina bifida who were treated unselec-
tively at Addenbrooke’s Hospital, Cambridge, UK from
1963 to 1971. After a meticulous neurological examination,
all had their backs closed within 48 hours of birth;15 if
required, a cerebrospinal fluid (CSF) shunt was inserted.
This was done in 89% (82/92) of infants who reached the
age of 1 year. Until 2012, the cohort had been reviewed
about every 5 years with no loss to follow-up.11,16–19 The
reviews at home and school at the mean ages of 4 years
and 9 years included clinical examination; in later reviews,
only those still attending Addenbrooke’s Hospital (51%,
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35/69 at mean age 18y) were examined. Later reviews were
based mainly on questionnaire surveys and clinical records.
The National Research Ethics Service Committee East of
England-Cambridge East reviewed the study (reference
07//Q0104/11).
Data collection
In 2016 and 2017, we conducted a confidential postal ques-
tionnaire survey of survivors backed by a telephone inter-
view with the patient and/or carer. Carers included parents,
partners, and/or health care staff. To ensure comparability,
we used the same questions as in previous reviews.16,17,19
Details of deaths up to August 2017 were obtained from
the Office for National Statistics and the Health and Social
Care Information Centre (flagged cohort MR564), backed
by information from medical records and autopsy reports.17
Statistical analysis
We defined walking as being able to walk more than 50m
independently outside with walking aids such as walking
sticks, crutches, callipers, or rollators, if needed.18 We
defined living independently as living without supervision
in the community, coping independently with housekeep-
ing, meals, all personal care needs, and transport. This
could include hiring a cleaner but did not include indepen-
dence in a sheltered environment where support can be
provided if needed.10,11
Using data from the 2016 and 2017 review and previous
reviews,11,15–20 we analysed trends in walking at the mean
ages of 9 years, 18 years, 25 years, 30 years, 35 years, 40
years, 45 years, and 50 years, and trends in living indepen-
dently from mean age 25 to 50 years. Previous studies sug-
gested that walking and survival were related to the level
of the lesion,5,12,14,21 whereas living independently was
related to CSF shunt history.11 We used Fisher’s exact test
to explore possible predictors of walking and living inde-
pendently at age 50 years. Survival may be better in those
less disabled who have a lower sensory level.12,16 We used
the logrank test with Kaplan–Meier curves to compare sur-
vival in those born with a sensory level below L3 versus
the remainder.
RESULTS
Follow-up in 2016 and 2017 was 99% (116/117). One
individual known to be alive in the Middle East in 2013
could no longer be contacted. There were 37 survivors of
whom 36 were interviewed by telephone (three supported
by a parent or health care worker), and one questionnaire
was completed by a parent. There had been 79 deaths.
Causes of death were: cardiorespiratory (26); neurological
(24: hydrocephalus [10]; central nervous system infection
[10]; epilepsy [4]); urological (22); and other causes (7:
inhaled vomit [2]; sudden infant death syndrome [1];
thrombocytopenic purpura [1]; carcinoma of the cervix [1];
malignant melanoma [1]; sepsis [1]). Forty members of the
cohort (34%) had died before the age of 5 years (25 before
their first birthday) and 39 (33%) during the following
45 years. The 50-year survival rate was 32% (37/116).
The mean age of the 37 survivors was 50 years (median:
50y; range: 46–53y), 17 were males and 20 were females.
Thirty-one survivors had a CSF shunt. In 11, the shunt
had never been revised, eight had revisions before the age
of 2 years, and 12 after 2 years (median number of revi-
sions in these 20 survivors: 2; range: 1–4). Fourteen sur-
vivors had a history of clinically documented symptoms or
signs of raised intracranial pressure.
Most survivors (29/37) had an IQ of more than 80 in
childhood (range: 51–137), and seven were fully continent
(without aids). Around half (20/37) had a sensory level at
birth below L3, 18 had a motor level below L3, and 26
had quadriceps activity recorded in infancy. Five worked in
open/competitive paid employment (three using wheel-
chairs) and two worked in sheltered employment. Thirteen
reported chronic pain in the head, neck, or back.
Walking
Figure 1 shows that the percentage of survivors who could
walk at least 50m at the mean ages of 9 years, 18 years, 25
years, 30 years, 35 years, 40 years, 45 years, and 50 years
was 51% (38/75), 50% (34/68), 33% (20/61), 30% (17/57),
30% (16/54), 30% (14/46), 31% (12/39), and 27% (10/37)
respectively. Of 38 who were defined as walkers at the
mean age of 9 years, 20 (53%) lost the ability to walk 50m
as they became older. Table I shows that the ability to
walk at age 50 years could be predicted from assessing sen-
sory level, motor level, or quadriceps activity at birth.
However, walking was not significantly related to IQ or
CSF shunt history.
Living independently
The percentage of survivors who lived independently in
the community at the mean ages of 25 years, 30 years, 35
years, 40 years, 45 years, and 50 years was 23% (14/61),
37% (21/57), 41% (22/54), 39% (18/46), 56% (22/39), and
54% (20/37) respectively. Over half (55%, 11/20) of those
living independently at age 50 years used wheelchairs.
Most of the cohort (67%, 41/61) showed no change in
independence over their lifespan (10 living independently,
31 not living independently). However, 12 improved (seven
at age 30y, two at age 40y, three at age 45y), two got
worse, and six fluctuated over time. Altogether, nearly half
(49%, 30/61) of those who survived to age 25 years and
beyond lived independently at some point. Table II shows
that compared to those needing daily care, survivors who
lived independently at the mean age of 50 years were less
What this paper adds
• By age 50 years, the percentage of patients who could walk more than 50m
had declined to 27%.
• By age 50 years, the percentage living independently had doubled to over
50%.
• Survivors without a history of raised intracranial pressure or cerebrospinal
fluid shunt revision are more likely to live independently.
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likely to have had clinically documented symptoms of
raised intracranial pressure or CSF shunt revisions, and
were more likely to be able to walk.
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Figure 1: Number of survivors walking and/or living independently according to age. One hundred per cent follow-up except at mean age 50y when we
could not contact one minimally affected case (with an S1 sensory level) who had been walking and living independently in 2013. Walking is defined as
being able to walk at least 50m independently outside with walking aids if needed,11 except at mean age 9y when walking is defined as ‘walks inde-
pendently’ or ‘sometimes uses wheelchair’. Living independently is defined as living without supervision in the community, and coping independently
with housekeeping, all personal needs, and transport.
Table I: Possible predictors of being able to walk more than 50m at age
50y in 37 survivors with open spina bifida
Predictor
Proportion with
predictor who
could walk (%)
Proportion without
predictor who could
walk (%) p
Birth sensory
level below
L3
9/20 (45) 1/17 (6) 0.017
Birth motor
level below
L3
8/18 (44) 2/19 (11) 0.048
Birth
quadriceps
activity
10/26 (38) 0/11 (0) 0.031
No CSF shunt
or shunt
revision
7/17 (41) 3/20 (15) 0.157
IQ at school
≥80
9/29 (31) 1/8 (13) 0.575
CSF, cerebrospinal fluid.
Table II: Possible predictors of living independently at age 50y in 37
survivors with open spina bifida
Predictor
Proportion with
predictor who live
independently (%)
Proportion without
predictor who live
independently (%) p
No history of
raised
intracranial
pressure
17/23 (74) 3/14 (21) 0.005
No CSF shunt
or shunt
revision
14/17 (82) 6/20 (30) 0.004
IQ at school
≥80
18/29 (62) 2/8 (25) 0.143
Can walk
≥50m at age
50y
9/10 (90) 11/27 (41) 0.017
Birth sensory
level below
L3
13/20 (65) 7/17 (41) 0.264
Birth motor
level below
L3
11/18 (61) 9/19 (47) 0.612
CSF, cerebrospinal fluid.
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Overall, median survival for the whole cohort was
29 years. Figure 2 shows that survival at the mean age
50 years was better in those born with sensation to pin-
prick below the knee (sensory level below L3) compared to
those born with a more extensive neurological deficit: 54%
(20/37) in those with a sensory level below L3 versus 22%
(17/79) in those with a sensory level of L3 and above
(logrank p=0.001).
DISCUSSION
Principal findings
The percentage of survivors with spina bifida who could
walk more than 50m declined from around half in child-
hood and adolescence to a quarter at age 50 years. How-
ever, partly because of the increased mortality in those
severely affected, the percentage living independently in
the community increased from around 25% at age 25 years
to over 50% at age 50 years. Living independently was
more likely in those who had never had symptoms of
raised intracranial pressure.
Strengths and limitations
This is the first cohort study to describe trends in walking
and living independently in patients with spina bifida up to
the mean age of 50 years. The long duration and over
99% follow-up make this study unique.21 The approach
and findings are novel (and different from previous reviews
of the same cohort) because we used longitudinal data on
mobility and independence from eight consecutive
assessments from 1985 to 2017. The study has other
strengths. This was an unselected cohort with a wide range
of disabilities. Neurological examination in infancy was
consistent and findings are at a relatively low risk of bias
because follow-up was done independently by clinicians
not involved in patient management.
The main limitation is that improvements in medical
management mean that our findings may not reflect the
prognosis for individuals born more recently. However,
our results are surprisingly similar to the postnatal repair
group in a recent 2011 trial, which compared prenatal and
postnatal repair of myelomeningocele:4 CSF shunt inser-
tion by age 12 months was 82% compared to 89% in our
cohort; independent walking was recorded in 57% (38/67)
of patients at age 2 years 6 months versus 51% (40/79) at
age 9 years in our cohort.15 Additionally, walking rates in
late adolescence were comparable to the only other unse-
lected prospective cohort study of spina bifida:13,21 46%
(33/71) at age 21 years versus 50% at age 18 years in our
cohort.
Other weaknesses include: the small size of the cohort,
although this is comparable with other studies.4,13 Later
reviews were mainly by telephone/postal questionnaire
rather than objective clinical assessment because many sur-
vivors had moved away from Cambridge. Findings may not
be generalizable to different systems of medical care or to
those of non-white ethnicity. Finally, this is a largely
descriptive analysis. The associations explored were based
on clinically likely effects,11–13 but we cannot rule out
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Figure 2: Fifty-year survival and neurological deficit at birth in 117 consecutive, unselected cases of open spina bifida. Those born with a sensory level
below L3 were more likely to survive than those with a higher sensory level (54% vs 22%, logrank p=0.001) at mean age 50y. One minimally affected
case (with an S1 sensory level) was lost to follow-up after the age of 43y. At age 50y, results have been censored for 17 cases who were alive (aged
46–49y) in August 2017.
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potential confounders for which we were unable to adjust
due to the small sample size.
Comparison with other studies
As described earlier, our results in childhood/adolescence
appear similar to more recent US studies of spina bifida
that started at or before birth, were non-selective, and fin-
ished recruiting in 197913 and 20104 respectively.
Our results for mobility are comparable to a large cross-
sectional study of patients enrolled in a US national spina
bifida patient registry, which found 45% were community
walkers at the mean age of 15 years,1 and to a smaller
study where 31% walked at the mean age of 30 years.9
Previous reports on living independently in adults with
spina bifida6,9,10 include cross-sectional studies of conve-
nience samples with mean ages of 21 to 31 years and
response rates of only 34% to 50%. These studies found
that 24% (12/50) were living independently at the mean
age of 21 years,6 and 30% (25/84) at the mean age of
31 years,9 which is comparable to our study. The authors
of the studies highlighted the need to investigate indepen-
dent living using community-based studies rather than
mainly focusing on those attending hospital clinics.
Implications
Our findings could influence clinical practice. The percent-
age of adults with spina bifida who could walk more than
50m declined over time, possibly because of deteriorating
health and increasing obesity.13,14 In our cohort, the pro-
portion who reported they were overweight or obese more
than doubled from 21% (13/61) at age 25 years to 44%
(24/54) at age 35 years. Weight management and/or exer-
cise programmes might improve mobility outcomes.1,5,22
Second, since a history of raised intracranial pressure
and/or CSF shunt revisions was associated with reduced
independence, doctors should consider prompt neuro-
surgical referral of patients with symptoms.23 Patients and
carers need to be aware of possible red flag symptoms
including headaches, nausea, drowsiness, unsteadiness, and/
or visual problems. Shunt malfunction, often unrecognised,
is a potentially avoidable cause of death and disability.5,21
Prompt neurosurgical assessment and treatment might pre-
serve function and independence.13
One reason for the increase over time in the percentage
of patients living independently is because survival was
better in those who were least disabled17,24 and had a
lower sensory level at birth. However, the 14% increase in
those living independently between the ages of 25 years
and 30 years might be partly related to the 1990s UK gov-
ernment policy promoting ‘care in the community’. This
involved encouraging people with disabilities to live at
home in specially adapted accommodation with visiting
support as needed; it also resulted in the closure of large
residential institutions. In addition, some of those depen-
dent on their parents as young adults later began living
independently when their parents died or became incapaci-
tated. Increasing use of the Internet and mobile phones
may also have made it easier for some individuals to live
independently.
Whether or not they live independently, patients with
spina bifida are also at high risk of sudden, unexpected
death.25 Nearly half (46%, 18/39) of those in our cohort
who died after the age of 5 years died suddenly, and
almost all these deaths were followed by a coroner’s post-
mortem. The most common causes were epilepsy, acute
hydrocephalus, pulmonary embolus, or acute renal sepsis.17
Sleep apnoea and mid-brain elongation may also be risk
factors for sudden death.25
This study may help families and health professionals to
have realistic expectations of long-term outcomes in spina
bifida. The two major factors predicting disability are the
neurological deficit at birth and a history of CSF
shunt.2,10–12,14,15 A less extensive neurological deficit/low
sensory level is associated with better long-term survival,
mobility, continence, and cognitive ability, and a reduced
risk of death caused by urological disorders.14–16,19 Not
needing a CSF shunt, or not needing a shunt revision, is
associated with independence.5,11,21 Finally, the unexpected
finding of a doubling over time in the percentage of sur-
vivors living independently might be widely applicable (e.g.
cerebral palsy) and deserves further research.
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